Mirtazapine
NDC 57237-012, Mirtazapine, tablet, orally disintegrating, from Rising Pharma Holdings, Inc..
- Product NDC
- 57237-012
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077376
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/57237-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRTAZAPINE30 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 57237-012-06 | 57237001206 | 5 BLISTER PACK in 1 CARTON (57237-012-06) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/73b7bbd9-7dba-4559-890f-3f8dd821e215NADAC price for package 57237001206
GET /v1/drugs/nadac/57237001206
Use it
Look up 57237-012 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/57237-012 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 57237-012. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.